Skip to main content
. 2020 Jan 8;2(1):vdaa002. doi: 10.1093/noajnl/vdaa002

Table 1.

Summary of Patient Data by Glioma Molecular Subtype and Sex

Female Male P-value
IDHwt GBM N 31 44
Mean age in yrs (SD) 65.26 (11.89) 63.00 (8.75) .35a
Age range 39–85 47–83
Adjusted median overall survivalc (months) [95% CI] 8.3 [6.6–15.3] 5.4 [4.7–12.0] .01b
Living (%) No 31 (100.00) 44 (100.00) NA
IDHwt non-GBM N 42 52
Mean age in yrs (SD) 49.18 (14.31) 53.83 (14.89) .14a
Age range 24–74 21–87
Adjusted median overall survivalc (months) [95% CI] 21.2 [16.8–60.0] 21.0 [16.4–27.2] .01b
Living (%) No 22 (52.4) 32 (61.5) .50d
Yes 20 (47.6) 20 (38.5)
IDHmut-codel non-GBM N 78 94
Mean age in yrs (SD) 46.44 (13.06) 44.12 (12.50) .24a
Age range 20–74 17–75
Adjusted median overall survivalc (months) [95% CI] NA [NA–NA] NA [68.4–NA] <.01b
Living (%) No 7 (9.0) 10 (10.6) .91d
Yes 71 (91.0) 84 (89.4)
IDHmut-non-codel non- GBM N 109 137
Mean age in yrs (SD) 38.65 (10.95) 37.23 (10.88) .31a
Age range 18–73 14–70
Adjusted median overall survivalc (months) [95% CI] 60 [60–NA] 368 [60–NA] .40b
Living (%) No 22 (20.2) 21 (15.3) .41d
Yes 87 (79.8) 116 (84.7)

Two IDHwt GBM patients, 1 male and 1 female, were missing 1p/19q co-deletion status data. Age data were missing for 3 females and 4 males in the IDHwt non-GBM subtype.

a P-value from t test.

b P-value from log-rank test.

cAdjusted for by age.

d P-value from chi-square test.